Gedivumab

Generic Name: Gedivumab

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 1807954-17-1

Unique Ingredient Identifier: 6IRE1TI49I

Background: Gedivumab is under investigation in clinical trial NCT01877785 (A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study of MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults

Phase 2

Completed

Conditions: Influenza A

Interventions: Drug: Placebo
Drug: MHAA4549A

First Posted Date: 2015-12-07

Last Posted Date: 2019-01-08

Lead Sponsor: Genentech, Inc.

Target Recruit Count: 124

Registration Number: NCT02623322

Locations: 🇺🇸
Oceane7 Clinical Research, Miami, Florida, United States
🇺🇸
North Alabama Research Center LLC, Athens, Alabama, United States
🇺🇸
Lalla-Reddy Medical Corporation, Fountain Valley, California, United States

and more 76 locations

A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection

Phase 2

Completed

Conditions: Influenza

Interventions: Drug: MHAA4549A
Drug: Placebo
Drug: Oseltamivir

First Posted Date: 2014-11-18

Last Posted Date: 2018-06-18

Lead Sponsor: Genentech, Inc.

Target Recruit Count: 168

Registration Number: NCT02293863

Locations: 🇲🇽
CEPREP; Hospital Universitario, Monterrey, Mexico
🇵🇱
Oddział Anestezjologii i Intensywnej Terapii Wojewódzki Specjalistyczny Szpital im dr Wł Biegańsk, Łódź, Poland
🇧🇬
MHAT "Dr. Tota Venkova"- Gabrovo, Gabrovo, Bulgaria

and more 168 locations

A Study of High Dose MHAA4549A in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: Placebo
Drug: MHAA4549A

First Posted Date: 2014-11-06

Last Posted Date: 2017-03-09

Lead Sponsor: Genentech, Inc.

Target Recruit Count: 14

Registration Number: NCT02284607

Locations: 🇨🇦
inVentiv Health Clinique, Quebec, Canada

A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer

Interventions: Drug: Placebo
Drug: MHAA4549A

First Posted Date: 2013-06-14

Last Posted Date: 2016-11-02

Lead Sponsor: Genentech, Inc.

Target Recruit Count: 21

Registration Number: NCT01877785

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy